This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bishai, W. R.
Right arrow Articles by Pitt, M. L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bishai, W. R.
Right arrow Articles by Pitt, M. L. M.

 Previous Article  |  Next Article 

Infection and Immunity, September 1999, p. 4931-4934, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Virulence of Mycobacterium tuberculosis CDC1551 and H37Rv in Rabbits Evaluated by Lurie's Pulmonary Tubercle Count Method

William R. Bishai,1,2,3 Arthur M. Dannenberg Jr.,1,4,5,6,* Nikki Parrish,6 Rafael Ruiz,1 Ping Chen,2 Bernard C. Zook,7 Walter Johnson,7 James W. Boles,8 and M. Louise M. Pitt8

Departments of Environmental Health Sciences,4 Molecular Microbiology and Immunology,1 International Health,2 and Epidemiology,5 School of Hygiene and Public Health, and Departments of Medicine3 and Pathology,6 School of Medicine, The Johns Hopkins University, Baltimore, Maryland; Departments of Pathology and Animal Research, The George Washington University Medical Center, Washington, D.C.7; and Department of Aerobiology and Product Evaluation, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland8

Received 9 February 1999/Returned for modification 17 February 1999/Accepted 27 May 1999


    ABSTRACT
Top
Abstract
Text
References

The virulence of the CDC1551 strain of Mycobacterium tuberculosis was compared to that of H37Rv in a rabbit inhalation model. While rabbits that inhaled the two strains produced equal numbers of grossly visible primary tubercles, CDC1551 tubercles were smaller and contained fewer bacilli than H37Rv tubercles. These findings suggest that a miniepidemic near the Kentucky-Tennessee border caused by CDC1551 was due not to increased virulence but to increased transmissibility.


    TEXT
Top
Abstract
Text
References

The CDC1551 strain of the tubercle bacillus, Mycobacterium tuberculosis, caused a local miniepidemic of clinical tuberculosis (TB) in the Kentucky-Tennessee border region (25). From 1994 to 1995, in a small rural community with a population at minimal risk for contracting TB, 21 patients were diagnosed with active TB. The source patient and index patient were identified by DNA fingerprint analyses with IS6110 and pTBN12 restriction fragment length polymorphisms. Among 429 TB patient contacts, 72% had positive (often large) tuberculin reactions, including 20% with documented skin test conversions. Only 3% of the noncontacts evaluated were tuberculin positive. These findings imply that the CDC1551 strain is more infectious than other TB strains, and studies with mice (25) also imply that it is more virulent.

Since TB in rabbits closely resembles that found in immunocompetent adult humans (3-7, 16-18, 22), we decided to compare the virulence of the CDC1551 strain with that of the H37Rv strain by Lurie's tubercle count method (8, 16, 19), which measures the ability of inhaled mycobacteria to establish clinical disease.

Pulmonary alveolar macrophages (AM) of rabbits destroy many inhaled tubercle bacilli before they multiply appreciably (1, 9-11, 16, 20). The AM of humans probably do the same. If the AM fail to destroy the inhaled tubercle bacilli, microscopic lesions are formed. Many of these newly formed microscopic lesions are prevented from reaching grossly visible size by the immune response of the host. (This response also converts the tuberculin reaction.) A reduction in the number of grossly visible primary pulmonary tubercles therefore reflects the power of the host immune response to prevent clinically apparent disease (8).

The virulence of the infecting bacilli can also be assessed by Lurie's tubercle count method (16). The more virulent the bacillus, the greater its resistance to destruction by both AM and the host's immune response. Therefore, bacilli of greater virulence produce more grossly visible tubercles.

Thus, with the appropriate controls, the number of visible tubercles present 5 weeks after the inhalation of bacilli provides an accurate measure of both host resistance and bacillary virulence (8, 16, 19, 19a). Also, the sizes of the pulmonary tubercles and the numbers of bacilli culturable from them (Tables 1 and 2) provide additional criteria to assess virulence (as well as acquired host resistance).

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   Characteristics of grossly visible tubercles generated in rabbits that inhaled the H37Rv or CDC1551 strain of virulent human-type tubercle bacilli 5 weeks previously


                              
View this table:
[in this window]
[in a new window]
  		TABLE 2.   Characteristics of representative pulmonary tubercles produced by rabbits that inhaled strain H37Rv or CDC1551 straina

Materials and methods. The CDC1551 strain (also known as the Oshkosh or CSU93 strain) was obtained from Thomas M. Shinnick, Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, Ga. H37Rv was obtained from the American Type Culture Collection, Manassas, Va. (catalog no. 27294). Both strains were mouse passaged immediately prior to their use in rabbits. Between receipt and mouse infection, CDC1551 and H37Rv were passaged three and eight times in vitro, respectively.

The number of bacilli in representative pulmonary tubercles (stored at -70°C) was determined by homogenizing each tubercle in a hand-driven Ten Broeck homogenizer and then plating the homogenates in various dilutions on complete Middlebrook 7H10 agar. The agar contained the following antimicrobials to control contamination by other bacteria: trimethoprim (20 µg/ml), polymyxin B (200 U/ml), carbenicillin (50 µg/ml), and cycloheximide (50 µg/ml). These antimicrobials were purchased from Sigma Chemical Co., St. Louis, Mo.

Pathogen-free rabbits (2.5 to 2.7 kg) were purchased from Covance Research Products, Inc., Denver, Pa. At the U.S. Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Frederick, Md., six of these rabbits were infected by aerosols of H37Rv, and six others were similarly infected by aerosols of CDC1551 (3). Briefly, just prior to infection, the tidal volume of air inhaled by each rabbit was measured in a whole-body plethysmograph (3). The number of viable bacilli in an aliquot of the air in the aerosol exposure chamber was measured by drawing the air through an all-glass impinger into an oleic acid-albumin solution (3), culturing this solution in various dilutions on solid Lowenstein-Jensen's medium, and counting the number of developing bacillary colonies after 3 to 4 weeks. The number of viable bacilli in the air that each rabbit breathed during exposure was then calculated from the tidal volume and the amount of infectious air drawn through the impinger.

After infection, the rabbits were housed in the biosafety level three facilities at George Washington University, Washington, D.C. Five weeks later, the animals were sacrificed, and the number of grossly visible primary tubercles in the lungs was counted as originally described by Lurie et al. (8, 16, 19).

All work with virulent tubercle bacilli was performed in a biosafety level three facility containing a laminar flow hood. All personnel wore HEPA-filtered respiratory devices, surgical gloves, and disposable protective clothing. The two-tailed Student t test was used to determine the P values presented in Tables 1 and 2.

These experiments were approved by the Institutional Animal Care and Use Committees of the three institutions where the work was performed. In conducting this research, the investigators adhered to the Guide for the Care and Use of Laboratory Animals (22a).

Results. Rabbits that inhaled CDC1551 and H37Rv produced equal numbers of grossly visible primary tubercles (Table 1). The average CDC1551 tubercle was smaller than the average H37Rv tubercle (Table 1) and contained fewer bacilli (Table 2). In contrast to the findings of Valway et al. for humans (25), we found that the CDC1551 strain did not induce enhanced tuberculin sensitivity in rabbits. In fact, it tended to induce less tuberculin sensitivity than H37Rv did (Table 1). In other words, the CDC1551 and H37Rv strains were equally effective in establishing clinically apparent disease in rabbits, and as determined from established lesions, the CDC1551 strain was not more virulent and was possibly less virulent.

Discussion. It has been known for years that all human-type tubercle bacilli are of lower virulence in rabbits than bovine-type tubercle bacilli (1, 8, 12, 13, 16, 19, 20). Both strains are probably equally virulent for humans (24), but modern human populations are rather resistant to TB compared to primitive human populations never before exposed to this disease (12, 13). Of those people with tuberculin reaction conversions, only about 10% will ever develop clinically apparent disease (2, 14).

In inbred susceptible and resistant strains of rabbits, an inhalation of 70 to 3,000 U of H37Rv was required to produce one grossly visible primary tubercle, depending on the genetic resistance of the host (16). In commercially available rabbits, the number of such units averaged 1,580 (Table 1). The number of inhaled bacillary units required to produce one grossly visible tubercle in humans is not known, but it probably lies somewhere between 20 and 200. Human-type tubercle bacilli sometimes produce progressive TB in humans, but they rarely do so in rabbits (16). Therefore, although rabbits and humans are both quite resistant to M. tuberculosis, humans are slightly less so.

We realize that some M. tuberculosis virulence factors may have more effect on humans than on rabbits. Rabbits are more susceptible to virulent bovine-type tubercle bacilli than virulent human-type bacilli, whereas humans (and mice) seem to be equally susceptible to the two types. Three other laboratories (15, 21, 23) have shown that the CDC1551 strain is not more virulent for mice than the H37Rv strain, and two of these laboratories (21, 23) have shown that it is even less so. Therefore, the lesser ability of CDC1551 to grow in rabbits was probably due to differences in the two strains of mycobacteria and not due to differences in the two animal species.

In mouse lungs, the CDC1551 strain did not grow as well as H37Rv after 14 days because CDC1551 induced a better host immune response (21). In rabbit lungs, smaller tubercles containing fewer bacilli were present in the CDC1551 group after 5 weeks (Tables 1 and 2), which also could be due to a more effective host immune response to the CDC1551 strain. The lower number of bacilli in the CDC1551 rabbits was probably the cause of their reduced tuberculin sensitivity at 5 weeks (Table 1).

The occurrence of the miniepidemic near the Kentucky-Tennessee border caused by the CDC1551 strain suggested that this strain is more infectious than other strains causing TB. Perhaps it has properties that let it survive better in the environment. It is also possible that the source, index, and secondary-source patients aerosolized more bacilli, and/or the airborne droplets that they produced were more stable and of a composition that enabled better bacillary survival. Our study did not address these environmental factors.

In the CDC1551 miniepidemic, the tuberculin converters did not show a greater-than-expected incidence of active TB (2, 25), and the patients diagnosed with clinical disease did not seem to have an unusually severe form. Such manifestations are consistent with our studies in rabbits: compared to H37Rv, the CDC1551 strain had no greater ability either to induce grossly visible pulmonary tubercles or to multiply within such tubercles.


    ACKNOWLEDGMENTS

We are indebted to Rena Ashworth, Marshall J. Urist, Richard Hitzelberg, and Maria Okalita for expert assistance in various parts of these studies.

This work was supported by NIH grants AI-35195 (A.M.D.), AI-36973 (W.R.B.), and AI-37856 (W.R.B.) from the National Institute of Allergy and Infectious Diseases, Bethesda, Md., and in part by grant ES-03819 (for the Johns Hopkins Environmental Health Sciences Center) from the National Institute of Environmental Health Sciences, Research Triangle Park, N.C.


    FOOTNOTES

* Corresponding author. Mailing address: Johns Hopkins School of Hygiene, 615 N. Wolfe St., Baltimore, MD 21205-2179. Phone: (410) 955-3062. Fax: (410) 955-0105. E-mail: artdann{at}jhsph.edu.

Editor:   S. H. E. Kaufmann


    REFERENCES
Top
Abstract
Text
References

1. Allison, M. J., P. Zappasodi, and M. B. Lurie. 1962. Host-parasite relationships in natively resistant and susceptible rabbits on quantitative inhalation of tubercle bacilli. Am. Rev. Respir. Dis. 85:553-569.
2. Bloom, B. R., and P. M. Small. 1998. The evolving relation between humans and Mycobacterium tuberculosis. N. Engl. J. Med. 338:677-678[Free Full Text].
3. Converse, P. J., A. M. Dannenberg, Jr., J. E. Estep, K. Sugisaki, Y. Abe, B. H. Schofield, and M. L. M. Pitt. 1996. Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli. Infect. Immun. 64:4776-4787[Abstract].
4. Converse, P. J., A. M. Dannenberg, Jr., T. Shigenaga, D. N. McMurray, S. W. Phalen, J. L. Stanford, G. A. W. Rook, T. Koru-Sengul, H. Abbey, J. E. Estep, and M. L. M. Pitt. 1998. Pulmonary bovine-type tuberculosis in rabbits: bacillary virulence, inhaled dose effects, tuberculin sensitivity, and Mycobacterium vaccae immunotherapy. Clin. Diagn. Lab. Immunol. 5:871-881[Abstract/Free Full Text].
5. Dannenberg, A. M., Jr. 1994. Rabbit model of tuberculosis, p. 149-156. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
6. Dannenberg, A. M., Jr. 1994. Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis. Immunobiology 191:461-473[Medline].
7. Dannenberg, A. M., Jr., and J. F. Tomashefski, Jr. 1998. Pathogenesis of pulmonary tuberculosis, p. 2447-2471. In A. P. Fishman, J. A. Elias, J. A. Fishman, M. A. Grippi, L. R. Kaiser, and R. M. Senior (ed.), Fishman's pulmonary diseases and disorders, 3rd ed., vol. 2. McGraw-Hill Co., Inc., New York, N.Y.
8. Dannenberg, A. M., Jr. 1998. Lurie's tubercle-count method to test TB vaccine efficacy in rabbits. Front. Biosci. 3:c27-c33. [Online.] http://www.bioscience.org/1998/v3/c/dannenbe/list.htm.
9. Dannenberg, A. M., Jr. 1991. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol. Today 12:228-233[Medline].
10. Dannenberg, A. M., Jr. 1993. Immunopathogenesis of pulmonary tuberculosis. Hosp. Pract. 28:33-40 or 51-58.
11. Dannenberg, A. M., Jr., and G. A. W. Rook. 1994. Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune responses---dual mechanisms that control bacillary multiplication, p. 459-483. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. American Society for Microbiology, Washington, D.C.
12. Dannenberg, A. M., Jr. 1984. Pathogenesis of tuberculosis: native and acquired resistance in animals and humans, p. 344-354. In L. Leive, and D. Schlessinger (ed.), Microbiology---1984. American Society for Microbiology, Washington, D.C.
13. Francis, J. 1958. Tuberculosis in animals and man. A study in comparative pathology. Cassell and Co., Ltd., London, England.
14. Gedde-Dahl, T. 1952. Tuberculous infection in the light of tuberculin matriculation. Am. J. Hyg. 56:139-214. [Medline]
15. Kelley, C. L., and F. M. Collins. Growth of a highly virulent strain of Mycobacterium tuberculosis in mice of differing susceptibility to tuberculous challenge. Tuber. Lung Dis., in press.
16. Lurie, M. B. 1964. Resistance to tuberculosis: experimental studies in native and acquired defensive mechanisms. Harvard University Press, Cambridge, Mass.
17. Lurie, M. B., and A. M. Dannenberg, Jr. 1965. Macrophage function in infectious disease with inbred rabbits. Bacteriol. Rev. 29:466-476.
18. Lurie, M. B. 1941. Heredity, constitution and tuberculosis, an experimental study. Am. Rev. Tuberc. 44(Suppl. 3):1-125.
19. Lurie, M. B., S. Abramson, and A. G. Heppleston. 1952. On the response of genetically resistant and susceptible rabbits to the quantitative inhalation of human-type tubercle bacilli and the nature of resistance to tuberculosis. J. Exp. Med. 95:119-134[Abstract].
19a. Lurie, M. B., P. Zappasodi, E. Cardona-Lynch, and A. M. Dannenberg, Jr. 1952. The response to the intracutaneous inoculation of BCG as an index of native resistance to tuberculosis. J. Immunol. 68:369-387.
20. Lurie, M. B., P. Zappasodi, and C. Tickner. 1955. On the nature of genetic resistance to tuberculosis in the light of host-parasite relationships in natively resistant and susceptible rabbits. Am. Rev. Tuberc. Pulm. Dis. 72:297-329.
21. Manca, C., L. Tsenova, C. E. Barry III, A. Bergtold, S. Freeman, P. A. Haslett, J. M. Musser, V. H. Freedman, and G. Kaplan. 1999. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J. Immunol. 162:6740-6746[Abstract/Free Full Text].
22. McMurray, D. N., F. M. Collins, A. M. Dannenberg, Jr., and D. W. Smith. 1996. Pathogenesis of experimental tuberculosis in animal models, p. 157-179. In T. M. Shinnick (ed.), Tuberculosis. Springer-Verlag, Berlin, Germany.
22a. National Research Council, Institute of Laboratory Animal Resources on Life Sciences. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
23. North, R. J., L. Ryan, R. LaCource, T. Mogues, and M. E. Goodrich. Growth rate of mycobacteria in mice as an unreliable indicator of mycobacterial virulence. Infect. Immun., in press.
24. Rich, A. R. 1951. The pathogenesis of tuberculosis, 2nd ed., p. 123-125. Charles C Thomas, Springfield, Ill.
25. Valway, S. E., M. P. C. Sanchez, T. F. Shinnick, I. Orme, T. Agerton, D. Hoy, J. S. Jones, H. Westmoreland, and I. M. Onorato. 1998. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N. Engl. J. Med. 338:633-639[Abstract/Free Full Text].

Infection and Immunity, September 1999, p. 4931-4934, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Agarwal, N., Woolwine, S. C., Tyagi, S., Bishai, W. R. (2007). Characterization of the Mycobacterium tuberculosis Sigma Factor SigM by Assessment of Virulence and Identification of SigM-Dependent Genes. Infect. Immun. 75: 452-461 [Abstract] [Full Text]  
  • Schluger, N. W. (2006). Assessing tuberculosis transmission and virulence: the vanishing tuberculin skin test.. Am. J. Respir. Crit. Care Med. 173: 942-943 [Full Text]  
  • Anderson, S. T., Williams, A. J., Brown, J. R., Newton, S. M., Simsova, M., Nicol, M. P., Sebo, P., Levin, M., Wilkinson, R. J., Wilkinson, K. A. (2006). Transmission of Mycobacterium tuberculosis Undetected by Tuberculin Skin Testing. Am. J. Respir. Crit. Care Med. 173: 1038-1042 [Abstract] [Full Text]  
  • Filliol, I., Motiwala, A. S., Cavatore, M., Qi, W., Hazbon, M. H., Bobadilla del Valle, M., Fyfe, J., Garcia-Garcia, L., Rastogi, N., Sola, C., Zozio, T., Guerrero, M. I., Leon, C. I., Crabtree, J., Angiuoli, S., Eisenach, K. D., Durmaz, R., Joloba, M. L., Rendon, A., Sifuentes-Osornio, J., Ponce de Leon, A., Cave, M. D., Fleischmann, R., Whittam, T. S., Alland, D. (2006). Global Phylogeny of Mycobacterium tuberculosis Based on Single Nucleotide Polymorphism (SNP) Analysis: Insights into Tuberculosis Evolution, Phylogenetic Accuracy of Other DNA Fingerprinting Systems, and Recommendations for a Minimal Standard SNP Set. J. Bacteriol. 188: 759-772 [Abstract] [Full Text]  
  • Manganelli, R., Fattorini, L., Tan, D., Iona, E., Orefici, G., Altavilla, G., Cusatelli, P., Smith, I. (2004). The Extra Cytoplasmic Function Sigma Factor {sigma}E Is Essential for Mycobacterium tuberculosis Virulence in Mice. Infect. Immun. 72: 3038-3041 [Abstract] [Full Text]  
  • Geiman, D. E., Kaushal, D., Ko, C., Tyagi, S., Manabe, Y. C., Schroeder, B. G., Fleischmann, R. D., Morrison, N. E., Converse, P. J., Chen, P., Bishai, W. R. (2004). Attenuation of Late-Stage Disease in Mice Infected by the Mycobacterium tuberculosis Mutant Lacking the SigF Alternate Sigma Factor and Identification of SigF-Dependent Genes by Microarray Analysis. Infect. Immun. 72: 1733-1745 [Abstract] [Full Text]  
  • Manabe, Y. C., Dannenberg, A. M. Jr., Tyagi, S. K., Hatem, C. L., Yoder, M., Woolwine, S. C., Zook, B. C., Pitt, M. L. M., Bishai, W. R. (2003). Different Strains of Mycobacterium tuberculosis Cause Various Spectrums of Disease in the Rabbit Model of Tuberculosis. Infect. Immun. 71: 6004-6011 [Abstract] [Full Text]  
  • Smith, I. (2003). Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence. Clin. Microbiol. Rev. 16: 463-496 [Abstract] [Full Text]  
  • Comstock, G. W. (2002). Tuberculosis transmission--rogue pathogen, rogue patient, or the vagaries of change?. Am. J. Respir. Crit. Care Med. 166: 1141-1142 [Full Text]  
  • Fleischmann, R. D., Alland, D., Eisen, J. A., Carpenter, L., White, O., Peterson, J., DeBoy, R., Dodson, R., Gwinn, M., Haft, D., Hickey, E., Kolonay, J. F., Nelson, W. C., Umayam, L. A., Ermolaeva, M., Salzberg, S. L., Delcher, A., Utterback, T., Weidman, J., Khouri, H., Gill, J., Mikula, A., Bishai, W., Jacobs, W. R. Jr., Venter, J. C., Fraser, C. M. (2002). Whole-Genome Comparison of Mycobacterium tuberculosis Clinical and Laboratory Strains. J. Bacteriol. 184: 5479-5490 [Abstract] [Full Text]  
  • Firmani, M. A., Riley, L. W. (2002). Mycobacterium tuberculosis CDC1551 Is Resistant to Reactive Nitrogen and Oxygen Intermediates In Vitro. Infect. Immun. 70: 3965-3968 [Abstract] [Full Text]  
  • Golub, J. E., Cronin, W. A., Obasanjo, O. O., Coggin, W., Moore, K., Pope, D. S., Thompson, D., Sterling, T. R., Harrington, S., Bishai, W. R., Chaisson, R. E. (2001). Transmission of Mycobacterium tuberculosis Through Casual Contact With an Infectious Case. Arch Intern Med 161: 2254-2258 [Abstract] [Full Text]  
  • Bishai, W. (2001). Tuberculosis Transmission-Rogue Pathogen or Rogue Patient?. Am. J. Respir. Crit. Care Med. 164: 1104-1105 [Full Text]  
  • Singh, K. K., Zhang, X., Patibandla, A. S., Chien, P. Jr., Laal, S. (2001). Antigens of Mycobacterium tuberculosis Expressed during Preclinical Tuberculosis: Serological Immunodominance of Proteins with Repetitive Amino Acid Sequences. Infect. Immun. 69: 4185-4191 [Abstract] [Full Text]  
  • Betts, J. C., Dodson, P., Quan, S., Lewis, A. P., Thomas, P. J., Duncan, K., McAdam, R. A. (2000). Comparison of the proteome of Mycobacterium tuberculosis strain H37Rv with clinical isolate CDC 1551. Microbiology 146: 3205-3216 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bishai, W. R.
Right arrow Articles by Pitt, M. L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bishai, W. R.
Right arrow Articles by Pitt, M. L. M.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»